文献速递青光眼角膜与眼表疾病

局部青光眼药物治疗与眼表微生物组改变相关

Topical Glaucoma Therapy Is Associated With Alterations of the Ocular Surface Microbiome.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2022-01-01

研究对17名受试者(10例单眼或不对称青光眼患者仅一眼使用局部降眼压药,7名年龄匹配健康对照)的眼表拭子行V3-V4 16S rRNA测序,比较三组微生物多样性与组成。患者用药眼和未用药眼的α多样性和革兰阴性菌相对丰度均显著高于健康对照,微生物组成与泪河高度和泪膜破裂时间降低相关,基于16S rRNA数据的宏基因组预测提示脂多糖合成增加。

要点

  • 患者用药眼和未用药眼的α多样性及革兰阴性菌相对丰度均显著高于健康对照。
  • 患者眼的微生物组成与泪河高度和泪膜破裂时间降低相关。
  • 基于16S rRNA数据的宏基因组预测提示脂多糖合成增加。

核心结论

  • 使用单侧含防腐剂青光眼滴眼液患者的眼表微生物组以高度多样的革兰阴性菌为特征,与健康对照眼主要检测到的革兰阳性微生物显著不同。
  • 这些组成差异与泪膜指标降低及不同的推断蛋白合成通路相关,提示微生物改变与眼表炎症之间可能存在关联。

研究设计与样本

  • 研究对17名受试者的双眼眼表拭子行V3-V4 16S rRNA测序,包括10例仅一眼使用局部青光眼治疗的单侧或不对称青光眼患者和7名年龄匹配、无眼病史或滴眼液使用史的健康对照。
  • 样本分为三组:患者使用滴眼液的治疗眼、患者未使用滴眼液的对侧眼和健康对照眼,比较微生物多样性和组成,并将组成差异与眼表疾病指标(泪河高度、泪膜破裂时间、干眼问卷)进行关联检验。

主要发现

  • 患者治疗眼和未治疗眼的样本α多样性和革兰阴性菌相对丰度均显著高于健康对照。
  • 患者眼的微生物组成与泪河高度和泪膜破裂时间降低相关。
  • 基于16S rRNA数据的宏基因组预测提示脂多糖合成增加。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the ocular surface microbiome of patients with unilateral or asymmetric glaucoma being treated with topical ophthalmic medications in one eye and to determine whether microbial community changes were related to measures of ocular surface disease. METHODS: V3-V4 16S rRNA sequencing was conducted on ocular surface swabs collected from both eyes of 17 subjects: 10 patients with asymmetric/unilateral glaucoma using topical glaucoma therapy on only one eye and seven age-matched, healthy controls with no history of ocular disease or eyedrop use. Samples were categorized into three groups: patients' glaucomatous eye treated with eyedrops, patients' contralateral eye without eyedrops, and healthy control eyes. Comparisons were made for microbial diversity and composition, with differences in composition tested for association with ocular surface disease measures including tear meniscus height, tear break-up time, and Dry Eye Questionnaire. RESULTS: Samples obtained from the patients' treated and untreated eyes both had significantly greater alpha-diversity and relative abundance of gram-negative organisms compared to healthy controls. The microbial composition of patient eyes was associated with decreased tear meniscus height and tear break-up time, whereas metagenomic predictions, based on 16S rRNA data, suggested increased synthesis of lipopolysaccharide. CONCLUSIONS: The ocular surface microbiome of patients taking unilateral preserved glaucoma drops is characterized by a highly diverse array of gram-negative bacteria that is significantly different from the predominantly gram-positive microbes detected on healthy control eyes. These compositional differences were associated with decreased tear film measures and distinct inferred protein synthesis pathways, suggesting a potential link between microbial alterations and ocular surface inflammation.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Chang CJ, Somohano K, Zemsky C, et al. Topical Glaucoma Therapy Is Associated With Alterations of the Ocular Surface Microbiome. Invest Ophthalmol Vis Sci. 2022. PMID: 36036910. doi:10.1167/iovs.63.9.32

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。